Design and Synthesis of Novel β-catenin/BCL9 Protein–Protein Interaction Small Molecule Inhibitors for the Treatment of Colorectal Cancer
Colorectal cancer (CRC) is one of the most common gastrointestinal malignancies. The development of novel targeted drug therapeutics against CRC has been a research hotspot. Among these strategies, disrupting the β-catenin/BCL9 protein–protein interaction (PPI) emerges as a promising approach for th...
Sparad:
| Huvudupphov: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Georg Thieme Verlag KG
2026-06-01
|
| Serie: | Pharmaceutical Fronts |
| Ämnen: | |
| Länkar: | http://www.thieme-connect.de/DOI/DOI?10.1055/a-2834-4404 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|